Pre-Open Stock Movers 01/19: (RSE) (ZPIN) (SHOP) Higher; (EBIO) (TIF) (MKC) Lower (more...)
Tweet Send to a Friend
Eleven Biotherapeutics, Inc. (NASDAQ: EBIO) 64% LOWER; announced top-line results from the Phase 3 clinical trial of its lead drug ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


